PurposeThe USA has a well-established network of central cancer registries (CCRs) that collect data using standardized definitions and protocols to provide population-based estimates of cancer incidence. The addition of cervical cancer precursors in select CCR operations would facilitate future studies measuring the population-level impact of human papillomavirus (HPV) vaccine. To assess the feasibility of collecting data on cervical cancer precursors, we conducted a multi-site surveillance study in three state-wide CCRs, to obtain annual case counts and compare rates of precursor lesions to those for invasive cervical cancer.MethodsWe developed standardized methods for case identification, data collection and transmission, training and qua...
Nearly 8 out of every 100,000 people are diagnosed with cervical cancer each year. However, powerful...
Background: High-quality Papanicolaou testing was developed in the 1940s, and when used for early de...
This supplement, known as the ABHACUS (Assessing the Burden of HPV-Associated Cancers in the United ...
Background: Cervical cancer prevention programs are being reconfigured to incorporate human papillo-...
Reducing cervical cancer disparities in the United States requires intentional focus on structural b...
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release ...
State immunization and cancer registries contain data that, if linked, could be used to monitor the ...
State immunization and cancer registries contain data that, if linked, could be used to monitor the ...
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release ...
Surveillance of cervical intraepithelial neoplasia grade III (CIN III) and adenocarcinoma in situ (A...
particularly for the 41% of plans ending in 2015 and the 31% ending between 2016-2020. Future studie...
particularly for the 41% of plans ending in 2015 and the 31% ending between 2016-2020. Future studie...
PurposeTo understand trends in the incidence and mortality of two human papillomavirus (HPV)-associa...
Human papillomavirus (HPV) causes approximately 30,000 cancers in the United States annually (1). HP...
Background: In spite of the general decline in cervical cancer incidence and the highly preventable ...
Nearly 8 out of every 100,000 people are diagnosed with cervical cancer each year. However, powerful...
Background: High-quality Papanicolaou testing was developed in the 1940s, and when used for early de...
This supplement, known as the ABHACUS (Assessing the Burden of HPV-Associated Cancers in the United ...
Background: Cervical cancer prevention programs are being reconfigured to incorporate human papillo-...
Reducing cervical cancer disparities in the United States requires intentional focus on structural b...
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release ...
State immunization and cancer registries contain data that, if linked, could be used to monitor the ...
State immunization and cancer registries contain data that, if linked, could be used to monitor the ...
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release ...
Surveillance of cervical intraepithelial neoplasia grade III (CIN III) and adenocarcinoma in situ (A...
particularly for the 41% of plans ending in 2015 and the 31% ending between 2016-2020. Future studie...
particularly for the 41% of plans ending in 2015 and the 31% ending between 2016-2020. Future studie...
PurposeTo understand trends in the incidence and mortality of two human papillomavirus (HPV)-associa...
Human papillomavirus (HPV) causes approximately 30,000 cancers in the United States annually (1). HP...
Background: In spite of the general decline in cervical cancer incidence and the highly preventable ...
Nearly 8 out of every 100,000 people are diagnosed with cervical cancer each year. However, powerful...
Background: High-quality Papanicolaou testing was developed in the 1940s, and when used for early de...
This supplement, known as the ABHACUS (Assessing the Burden of HPV-Associated Cancers in the United ...